GSK (GSK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good ...

ShareThe year 2024 etched an indelible mark on Nigeria’s economic history as over 20 highprofile multinational corporations, including Unilever Nigeria Plc, Procter & Gamble, GlaxoSmithKline Consumer ...

Prince Harry makes emotional plea for WellChild nominations - The WellChild awards celebrate the inspiring qualities of the ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.

Over the weekend, Chiefs Wire’s Ed Easton Jr. spoke to accomplished actress Gina Torres at a remarkable and informative women ...

Chiefs Wire’s @EdEastonJr spoke to iconic actress and author Brooke Shields at a women’s empowerment brunch hosted by Donna ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

As of 13 January at 1:54:51 pm GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

As of 13 January at 3:13:05 pm GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.